Recombinant methioninase in combination with doxorubicin (DOX) overcomes first-line DOX resistance in a patient-derived orthotopic xenograft nude-mouse model of undifferentiated spindle-cell sarcoma

JOURNAL ARTICLE published March 2018 in Cancer Letters

Authors: Kentaro Igarashi | Kei Kawaguchi | Shukuan Li | Qinghong Han | Yuying Tan | Takashi Murakami | Tasuku Kiyuna | Kentaro Miyake | Masuyo Miyake | Arun S. Singh | Mark A. Eckardt | Scott D. Nelson | Tara A. Russell | Sarah M. Dry | Yunfeng Li | Norio Yamamoto | Katsuhiro Hayashi | Hiroaki Kimura | Shinji Miwa | Hiroyuki Tsuchiya | Shree Ram Singh | Fritz C. Eilber | Robert M. Hoffman